To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.
Spécifications
- Description:NFKB Phosphorylation Assay Kit
- Size:100 assays
- Method:FL360/450 nm, 530/585 nm
- Species reactivity:Human, mouse
- Sample:Cell, tissue, etc.
- Processing time:Eight hours
- Cat. no.:75878-154
- Supplier No.:ENFKB-100
Spécifications
A propos de cet article
For quantitative fluorescent immunoenzymatic assay of NFkB phosphorylation status in cultured cells.
- Simple and convenient
- No cell lysis necessary
Nuclear factor-kappa B (NFkB) is a transcription factor that plays a central role in many physiological processes, e.g
BioAssay Systems’ cell-based ELISA measures phosphorylated p65(S536) (pNFkB) in whole cells and normalizes the signal to the total protein content. This simple and efficient assay eliminates the need for cell lysate preparation and can be used to study NFkB regulation in short-term and long-term assays.
inflammation, tumorigenesis, and apoptosis. NFkB is activated by a wide variety of stimuli, including inflammatory cytokines such as TNF-α. NFkB is a dimer composed of members of the Rel family of proteins: p65/RelA, c-Rel, RelB, NFkB1/p50, and NFkB2/p52. Phosphorylation of p65/RelA at Ser-536 results in decreased nuclear export and enhanced p65/RelA-dependent transcription.